DENVER, June 6, 2019 /PRNewswire/ — Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, announced today that it has entered into a securities purchase agreement for the sale of up to $14 million of the Company’s common stock from an affiliate of Dye Capital & Company (“Dye Capital”).
NEW YORK, June 6, 2019 /PRNewswire/ — Lucid Green Inc., is the leading Cannabis trust and transparency platform that delivers vital product usage, safety and feedback information to consumers. Today Lucid Green launches the first Cannabis digital platform for products that centralizes a Brands product assets into one place, which can then be distributed “in real time” to all partners. Brands can now control the consistency of their product messaging and imagery. Lucid Green is making it easier for partners to spread the love, ensuring that all product details and descriptions across all channels contain the same unified messaging: from retailers for on-line menus and inventory control, to journalists and labs for product shots and descriptions.
WOODLAND HILLS, Calif., June 6, 2019 /PRNewswire/ — Freedom House Reentry Education and Employment Corp. (FREE) is pleased to announce that Laura Kaeppeler-Fleiss, former 2012 Miss America and wife of The Bachelor creator Mike Fleiss, has joined the Board of Trustees of Freedom House Reentry Education and Employment Corporation (FREE).
TORONTO, June 6, 2019 /PRNewswire/ – SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE:SOL) (Frankfurt:9SB) (OTCQB: SOLCF) announces that it has acquired an aggregate of 4,831,500 common shares and 2,349,500 common share purchase warrants of Frankly Inc. (“Frankly”) (TSX-V:TLK), representing 16.3% of the issued and outstanding common shares of Frankly on a non-diluted basis and 22.5% of Frankly on a partially diluted basis. SOL Global acquired an initial aggregate position of 4,700,000 common shares and the 2,349,500 common share purchase warrants between May 10, 2019 and May 22, 2019 pursuant to a private placement offering of Frankly units at a price of $0.35 per unit for an aggregate purchase price of $1,645,000 (the “Frankly Private Placement”). Each unit was comprised of one (1) common share of Frankly and one-half (1/2) of one warrant with each whole warrant exercisable for one common share of Frankly at an exercise price of $0.65 for a period of 24 months from the issue date. SOL Global did not hold any securities of Frankly prior to the Frankly Private Placement.
VANCOUVER, June 6, 2019 /CNW/ – Pasha Brands Ltd. (“Pasha”) (CSE:CRFT), one of Canada’s largest craft cannabis brands organization, is announcing that it has acquired Medcann Health Products Ltd. (“Medcann”), a fully licensed, Health Canada approved standard facility to process, cultivate and sell medical cannabis under the Cannabis Act regulations. Prior to its acquisition by Broome Capital Inc., the privately held Pasha Brands Ltd. had previously entered into a letter of intent to acquire Medcann, dated effective April 30, 2019.
TORONTO, June 6, 2019 /PRNewswire/ – Beleave Inc. (“Beleave” or the “Company”) (CSE: BE; OTCQX: BLEVF) today announces a settlement with the British Columbia Securities Commission (“BCSC”), and provides updates to certain prior disclosure regarding agreements entered into and shares issued by the Company during its fiscal year ended March 31, 2019. All values in this news release are in Canadian dollars.
– Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors led by Charles Pollack, Jr. MD, FACEP
NEW YORK, June 6, 2019 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Plus Products Inc. (CSE: PLUS; OTCQX: PLPRF), a leading cannabis branded products company in the U.S., has qualified to trade on the OTCQX® Best Market. Plus Products upgraded to OTCQX from the OTCQB® Venture Market.
TSX-Venture Exchange: SUGR, SUGR.WT
CHATHAM, ON, June 6, 2019 /CNW/ – AgMedica Bioscience Inc. (“AgMedica” or the “Company”), a licensed producer of cannabis for medicinal and adult-use consumers, is pleased to announce that it has received approval from Health Canada for a license amendment allowing for the sale of cannabis oil products, effective May 31, 2019. The cannabis oil sales license enables AgMedica to provide medicinal patients and adult-use consumers with greater choice through a portfolio of bottled oils that includes CBD, THC and Balanced varieties, all of which are considered higher-demand products.